NASDAQ:CSBR

Champions Oncology Earnings Date, Estimates & History

$10.86
-0.44 (-3.89 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.66
Now: $10.86▼
$11.53
50-Day Range
$10.72
MA: $11.71▼
$13.75
52-Week Range
$7.05
Now: $10.86▼
$14.68
Volume22,115 shs
Average Volume30,982 shs
Market Capitalization$145.42 million
P/E RatioN/A
Dividend YieldN/A
Beta1.2

Earnings

Champions Oncology (NASDAQ:CSBR) Earnings Information

Champions Oncology last released its earnings data on March 11th, 2021. The biotechnology company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.04. The company had revenue of $10.81 million for the quarter, compared to analyst estimates of $10.29 million. Champions Oncology has generated ($0.17) earnings per share over the last year. Champions Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 26th, 2021 based off prior year's report dates.

Champions Oncology Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Champions Oncology (NASDAQ:CSBR) Earnings Estimates

Current Year EPS Consensus Estimate: $0.02 EPS
Next Year EPS Consensus Estimate: $0.15 EPS

Champions Oncology (NASDAQ CSBR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/26/2021
(Estimated)		       
3/11/2021Q3 2021$0.01$0.05$0.05$10.29 million$10.81 millionListen
12/14/2020Q2 2021$0.01$0.01$9.63 million$10.12 millionListen
9/14/2020Q1 2021$0.02$0.0059$0.01$8.74 million$9.55 millionTranscript
7/29/2020Q4$0.01($0.14)($0.17)$8.48 million$8.75 millionTranscript
3/12/2020Q3 2020$0.02$0.03$0.03$8.07 million$9.01 millionN/A
12/16/2019Q2($0.0170)$0.02$0.02$7.83 million$7.63 millionTranscript
9/16/2019Q1 2020$0.03($0.06)($0.06)$7.50 million$6.74 millionN/A
7/15/2019Q4 2019$0.03($0.02)($0.02)$6.60 million$7.72 millionN/A
3/18/2019Q3 2019$0.02($0.03)($0.03)$6.48 million$6.43 millionN/A
12/17/2018Q2$0.04$0.03$0.02$6.35 million$6.69 millionTranscript
9/13/2018Q1 2019$0.01$0.04$0.04$5.85 million$6.23 millionTranscript
7/27/2018Q4 2018($0.04)($0.04)($0.06)$5.05 million$4.92 millionN/A
3/15/2018Q3 2018($0.01)($0.01)$5.08 millionTranscript
12/7/2017Q2 2018($0.01)($0.01)$5.20 millionTranscript
9/14/2017Q1 2018($0.06)($0.06)$5.03 millionN/A
7/27/2017Q4 2017($0.22)($0.22)$3.72 millionN/A
3/16/2017Q3 2017($0.13)($0.13)$3.57 millionN/A
11/29/2016Q2 2017($0.05)($0.05)$4.46 millionN/A
9/9/2016Q1 2017($0.26)($0.26)$3.67 millionN/A
7/28/2016Q4 2016($0.30)($0.30)$2.84 millionN/A
3/15/2016Q316($0.21)($0.28)$1.80 million$2.60 millionListen
12/14/2015Q2 2016($0.29)($0.29)$2.97 millionN/A
9/10/2015Q1 2016($0.33)($0.33)$2.82 millionN/A
7/28/2015Q4 2015($0.60)($0.60)$3.24 millionN/A
3/17/2015Q3 2015($0.48)($0.48)$1.83 millionN/A
12/12/2014Q2 2015($0.60)($0.60)$1.88 millionN/A
9/11/2014Q1 2015($0.60)($0.60)$1.91 millionN/A
7/24/2014Q4 2014($0.36)($0.36)$2.46 millionN/A
3/13/2014Q3 2014($0.12)($0.12)$3.69 millionN/A
12/12/2013Q2 2014($0.36)($0.36)$2.38 millionListen
9/13/2013Q1 2014($0.36)($0.36)$3.02 millionN/A
7/26/2013Q4 2013($0.36)($0.36)$1.84 millionN/A
3/14/2013Q3 2013($0.24)($0.24)$2.92 millionN/A
12/13/2012Q2 2013($0.48)($0.48)N/A
9/12/2012Q1 2013($0.34)($0.32)N/A
7/18/2012Q4 2012($0.72)($0.72)N/A
3/14/2012Q3 2012($0.44)($0.44)N/A
12/14/2011Q2 2012($0.60)($0.60)N/A
9/13/2011Q1 2012($0.48)($0.48)N/A
7/15/2011Q4 2011($0.84)($0.84)N/A
3/7/2011Q3 2011($0.24)($0.24)N/A
9/13/2010Q1 2011($0.20)($0.20)N/A
7/28/2010Q4 2010($0.24)($0.24)N/A
3/17/2010Q3 2010($0.28)($0.28)N/A
12/15/2009Q2 2010($0.22)($0.22)N/A
9/14/2009Q1 2010($0.37)($0.37)N/A
3/18/2009Q3 2009($0.23)($0.23)N/A
12/16/2008Q2 2009($0.12)($0.12)N/A
9/16/2008Q1 2009($0.12)($0.12)N/A
3/6/2008Q3 2008$0.24$0.24N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 4/22/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.